Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

QILU

  • FDA Approval
  • Sept. 17, 2025, 04:24 UTC
  • 19
  • 0 comments

FDA approve CYCLOSPORINE

Comment Full text

ASTRAZENECA

  • FDA Approval
  • Sept. 16, 2025, 08:48 UTC
  • 18
  • 0 comments

FDA approve ALBUTEROL SULFATE; BUDESONIDE

Comment Full text

MEITHEAL

  • FDA Approval
  • Sept. 16, 2025, 08:48 UTC
  • 25
  • 0 comments

FDA approve HALOPERIDOL DECANOATE

Comment Full text

WATSON LABS

  • FDA Approval
  • Sept. 16, 2025, 08:48 UTC
  • 16
  • 0 comments

FDA approve METOPROLOL TARTRATE

Comment Full text

TEVA PHARMS USA INC

  • FDA Approval
  • Sept. 16, 2025, 08:48 UTC
  • 19
  • 0 comments

FDA approve MACITENTAN

Comment Full text

HOSPIRA

  • FDA Approval
  • Sept. 16, 2025, 04:09 UTC
  • 19
  • 0 comments

FDA approve POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC

Comment Full text

CORSTASIS THERAPEUTICS

  • FDA Approval
  • Sept. 15, 2025, 18:57 UTC
  • 21
  • 0 comments

FDA approve BUMETANIDE

Comment Full text

INVAGEN PHARMS

  • FDA Approval
  • Sept. 15, 2025, 08:54 UTC
  • 22
  • 0 comments

FDA approve TERBINAFINE HYDROCHLORIDE

Comment Full text

APOTEX INC

  • FDA Approval
  • Sept. 15, 2025, 08:54 UTC
  • 20
  • 0 comments

FDA approve RISPERIDONE

Comment Full text

ACTAVIS ELIZABETH

  • FDA Approval
  • Sept. 15, 2025, 08:54 UTC
  • 17
  • 0 comments

FDA approve DILTIAZEM HYDROCHLORIDE

Comment Full text
  • Previous
  • 18
  • 19
  • 20
  • 21
  • 22
  • Next

Search

News categories

  • Technical Exchange News(10266)
  • Event(1436)
  • SEC News(174176)
  • FDA Approval(9605)
  • Company Report(721)
  • Business News(116926)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin